FUMOT launches 4-in-1 e-cigarette in UK, meeting TPD standards

Nov.06.2024
FUMOT launches 4-in-1 e-cigarette in UK, meeting TPD standards
The new Fumot Tornado 4-in-1 e-cigarette from FUMOT is now available on UK sites like Vapesourcing and Powervapeshop. The product complies with EU TPD standards and offers approximately 4,000 puffs.

Recently, 2Firsts noted that FUMOT's new 4-in-1 product, the Fumot Tornado 4in1, has been listed on the brand's official website as well as on UK e-cigarette distributor sites like Vapesourcing and Powervapeshop. The product complies with TPD standards and offers approximately 4,000 puffs.

 

FUMOT launches 4-in-1 e-cigarette in UK, meeting TPD standards
Fumot Tornado 4in1 | Image source: vapesourcing

 

Specifically, the features of the Fumot Tornado 4in1 include:

 

FUMOT launches 4-in-1 e-cigarette in UK, meeting TPD standards
Mapping: 2Firsts

 

At the InterTabac tobacco exhibition held in September, the FUMOT brand was interviewed by the 2Firsts team. Brand representatives said, "New large disposable products that meet TPD standards are emerging," and emphasized the importance of actively complying with regulatory standards for long-term stability. The brand also launched several innovative products, such as "2+10," at the exhibition to meet the demands of the German market.

 

FUMOT launches 4-in-1 e-cigarette in UK, meeting TPD standards
FUMOT brand products are listed on the vapesourcing website|Image source: vapesourcing

 

According to observations by 2Firsts, websites that offer online sales of FUMOT e-cigarettes in the UK are relatively limited. FUMOT products were not found on popular sites such as VapeUK, VapeClub, eCigaretteDirect, and ZeroVapes. However, on sites like Vapesourcing and PowerVapeShop, where FUMOT products are available, the offerings mainly consist of high-puff disposable e-cigarettes.

 

In a review article on the Fumot Tornado 4in1 by the e-cigarette website *Planet of the Vapes*, it was noted: “They [referring to the FUMOT brand] have many devices that do not comply with TPD (Tobacco Products Directive) regulations, but also a few that do, which is why their business is global.”

 

“Some of the flavors [of the Fumot Tornado 4in1] are indeed well-blended.”

 

“Since they are 4-in-1, you might find a flavor in the pack you purchase that you don’t enjoy.”

 

FUMOT launches 4-in-1 e-cigarette in UK, meeting TPD standards
Review article of the Fumot Tornado 4in1 released by planetofthevapes|Image source planetofthevapes

 

FUMOT launches 4-in-1 e-cigarette in UK, meeting TPD standards
Review article of Fumot Tornado 4in1 published by Planet of the Vapes | Image source: Planet of the Vapes

 

It is worth noting that on FUMOT’s official website, a separate “TPD Series” section is listed under the product category, featuring products compliant with TPD standards. This series includes low-puff disposables, open systems, refillable models, and 4-in-1 multi-flavor devices.

 

FUMOT launches 4-in-1 e-cigarette in UK, meeting TPD standards
FUMOT official website TPD Series | Image source: FUMOT official website

 

2Firsts will continue to monitor the latest e-cigarette products and market trends globally, providing the public with accurate and authoritative industry information.

 


 

2Firsts' product column remains committed to delivering readers the latest product updates in the new tobacco field. We invite readers to submit insights and news on e-cigarette developments.

 

For unique perspectives or information, feel free to contact us at carrie.cai@2firsts.com or scan the QR code below.

 

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

JAMA Issues First U.S. Clinical Guidance on Vaping for Smoking Cessation, Urging Complete Switch From Cigarettes
JAMA Issues First U.S. Clinical Guidance on Vaping for Smoking Cessation, Urging Complete Switch From Cigarettes
JAMA has published a Special Communication offering systematic recommendations for U.S.-based clinicians on the use of nicotine e-cigarettes in adult smoking cessation. Developed by the Harm Reduction Workgroup of the Society for Research on Nicotine and Tobacco’s Treatment Research Network, the paper recommends including e-cigarettes alongside FDA-approved cessation medications in risk-benefit discussions. It cites high-certainty evidence that nicotine e-cigarettes achieve higher quit rates than nicotine replacement therapy and evidence suggesting efficacy comparable to highly effective medications such as varenicline and cytisine. For adults who choose vaping to quit, the authors recommend FDA-authorized products, sufficient nicotine delivery and a rapid, complete transition away from cigarettes rather than prolonged dual use.
Aug.13
Yinghe-Controlled Vape Maker SKE Ordered to Post £569,039 Security as It Pursues Crystal Bar Design Infringement Case in UK
Yinghe-Controlled Vape Maker SKE Ordered to Post £569,039 Security as It Pursues Crystal Bar Design Infringement Case in UK
The UK High Court has ordered Chinese vape manufacturer Shenzhen SKE Technology to provide £569,039 ($776,000) in security for costs in its design infringement proceedings against Vapepen London and other defendants over its Crystal Bar vape product. The court did not accept the defendants’ main argument that recovering costs from a China-based company would face significant enforcement obstacles, but found that SKE had not sufficiently disclosed its own financial position. The order is procedural and does not determine the underlying infringement claims.
News
Aug.21
Trump Names Darrell Scott as CDC Tobacco Health Adviser, Citing Tobacco Risks and Harm-Reduction Solutions
Trump Names Darrell Scott as CDC Tobacco Health Adviser, Citing Tobacco Risks and Harm-Reduction Solutions
U.S. President Donald Trump has named Pastor Darrell Scott to serve as an adviser on tobacco health issues on the Centers for Disease Control and Prevention’s Advisory Committee to the Director. Trump said Scott would focus on the burden of tobacco-related disease and help examine ways to protect Americans from dangerous tobacco products while supporting solutions that reduce harm. Scott’s public career has largely centered on faith leadership, community advocacy and politics.
Sep.02
2FIRSTS EXCLUSIVE|China Breaks Up $6.8 Million Illegal Hookah Tobacco Operation as Market Expands
2FIRSTS EXCLUSIVE|China Breaks Up $6.8 Million Illegal Hookah Tobacco Operation as Market Expands
Chinese authorities have dismantled an illegal hookah tobacco operation worth more than 46 million yuan ($6.8 million), detaining five foreign suspects and seizing over 500,000 boxes of tobacco paste. The case comes as hookah expands across China’s nightlife sector and attracts overseas operators, including former vaping entrepreneurs. It also raises a central regulatory question: whether waterpipe tobacco will follow China’s private-sector e-cigarette licensing model or be reserved for the state tobacco system, as with nicotine pouches, in the years ahead.
Jul.31
UK Reform Party Proposes Cap of 1,000 Vape Shops Under Plan to Tighten Retail Controls
UK Reform Party Proposes Cap of 1,000 Vape Shops Under Plan to Tighten Retail Controls
The UK Reform Party has proposed limiting the number of dedicated vape shops in the country to around 1,000 as part of a plan to tighten oversight of vape retail channels. The proposal was put forward by Reform UK deputy leader and MP Lee Anderson. The plan remains a political proposal and has not become UK government policy, with no detailed legislation, implementation timeline or allocation rules announced.
Aug.10
PMI Expands U.S. ZYN Portfolio With New 1.5 mg and 8 mg Strengths, Moves Toward a Unified 20-Pouch-Per-Can Format
PMI Expands U.S. ZYN Portfolio With New 1.5 mg and 8 mg Strengths, Moves Toward a Unified 20-Pouch-Per-Can Format
Philip Morris International is expanding its U.S. ZYN nicotine pouch portfolio with new 1.5 mg and 8 mg strengths and plans to move its core 3 mg and 6 mg dry-pouch products from 15 to 20 pouches per can in the fourth quarter of 2026. ZYN ULTRA is also commercially available, with FDA authorization covering 10 products at 9 mg and one 11 mg Smooth product. PMI U.S. lists the new 1.5 mg and 8 mg strengths as commercially available, but as of September 10 they do not appear on the FDA’s public authorization list. Public materials do not identify which PMTA submissions cover the two new strengths or their current review status.
Sep.11